Vācija -
vācu -
BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)
ribavirin-ct 400 mg filmtabletten
abz-pharma gmbh - geschäftsanschrift - (4238075) - ribavirin - filmtablette - ribavirin (24336) 400 milligramm
Vācija -
vācu -
BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)
ribavirin-ct 200 mg filmtabletten
abz-pharma gmbh - geschäftsanschrift - (4238075) - ribavirin - filmtablette - ribavirin (24336) 200 milligramm
Vācija -
vācu -
BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)
ribavirin hexal 200 mg hartkapseln
h e x a l aktiengesellschaft (3079284) - ribavirin - hartkapsel - ribavirin (24336) 200 milligramm
Vācija -
vācu -
BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)
ribavirin hexal 200 mg hartkapseln
h e x a l aktiengesellschaft (3079284) - ribavirin - hartkapsel - ribavirin (24336) 200 milligramm
Vācija -
vācu -
BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)
ribavirin-ratiopharm 200 mg filmtabletten
ratiopharm gmbh (3087881) - ribavirin - filmtablette - ribavirin (24336) 200 milligramm
Vācija -
vācu -
BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)
ribavirin-ratiopharm 400 mg filmtabletten
ratiopharm gmbh (3087881) - ribavirin - filmtablette - ribavirin (24336) 400 milligramm
Šveice -
vācu -
Swissmedic (Swiss Agency for Therapeutic Products)
copegus 200 mg filmtabletten
roche pharma (schweiz) ag - ribavirinum - filmtabletten - ribavirinum 200 mg, excipiens pro compresso obducto. - chronische hepatitis c, kombinationstherapie mit interferon - synthetika
Šveice -
vācu -
Swissmedic (Swiss Agency for Therapeutic Products)
copegus 400 mg filmtabletten
roche pharma (schweiz) ag - ribavirinum - filmtabletten - ribavirinum 400 mg, excipiens pro compresso obducto. - chronische hepatitis c, kombinationstherapie mit interferon - synthetika
Šveice -
vācu -
Swissmedic (Swiss Agency for Therapeutic Products)
rebetol kapseln
msd merck sharp & dohme ag - ribavirinum - kapseln - ribavirinum 200 mg, color.: e 132, excipiens pro kapsel. - chronische hepatitis c, kombinationstherapie mit interferon - synthetika
Eiropas Savienība -
vācu -
EMA (European Medicines Agency)
sutent
pfizer limited - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastische mittel - gastrointestinal stromal tumour (gist)sutent is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib mesilate treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sutent is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours with disease progression in adults. experience with sutent as first-line treatment is limited (see section 5.